cadenas

ITCC-050 LENVATINIB

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-050 LENVATINIB

Phase 1/2 Study of Lenvatinib (E7080) in Children and Adolescents with Relapsed or Refractory Solid Malignancies

Promotor Name : Eisai

Investigator Name : N. GASPAR

Trial registered on clinicaltrials.gov: NCT02432274